Top Internet Picks for Q4
Given the recent selloff in Internet shares, we believe it is prudent to take a closer look at Internet performance and valuations from a historical context as well as our picks for the remainder of 2013.
We have a positive bias on shares of Google (GOOG), Yahoo (YHOO), Facebook (FB) and believe Amazon. (AMZN) will largely be viewed as a defensive name in the group.
The Street Insider September 23, 2013
Celldex Therapeutics (CLDX) Target Raised to $45 at Leerink Swann
Leerink Swann maintained an Outperform rating on Celldex Therapeutics (NASDAQ: CLDX) and raised its price target to $45.00 (from $28.00). Analyst Howard Liang discussed views on CDX-1127 as an immunotherapy play.
"Ahead of first clinical data on CDX-1127 expected at the Society for Immunotherapy of Cancer (SITC) meeting (Nov. 7-10, National Harbor, MD), we spoke with several MEDACorp key opinion leaders (KOLs) and closely examined available data. Our work enhances our conviction that the potential of immuno-oncology (IO) agents could go far beyond the already impressive data shown so far for PD-1 immune checkpoint inhibitors, and we see an analogy to the HCV space in that the winner may lie in the best combination instead of the best anti-PD1 compound," said Liang.
Wall Street Journal
Tesla’s Tumble Is a Buying Opportunity
Do the DD.
The Fly On The Wall 9/24/13
Facebook initiated with a Buy at Canaccord
Canaccord initiated Facebook with a Buy and said the company is in the early stages of monetizing the user base. The firm notes Facebook's global penetration is only about 20% and sees upside from Instagram magnetization and the upcoming launch of the video ad product. Target $60.
NO BRAINER UNDERVALUED
This Weeks 5 Smartest Moves
September 27, 2013 Sat.
Analyst Heather Bellini is boosting Facebook's price target from $52 to $58, inspired by a healthy Adweek 2013 presentation and receptive advertisers.
Earlier in the week it was reported China will be allowing Facebook and other foreign social-media giants back into Shanghai's Free-trade Zone. Opening access in a single area isn't ideal, but it's a positive signthat China's willing to dip its toes in this Internet ocean after banning most foreign social-media sites four years ago.
Seeking Alpha Market Currents
Facebook price target hiked at JPMorgan, CLSA
Expecting strong advertising traction to build into the end of the year, JPMorgan reiterates its Buy rating on Facebook (FB) and ups the price target to $53 from $44. The team is raising its mobile and desktop estimates, and projects mobile will surpass 50% of total ad revenues in Q4.
CLSA one-ups JPMorgan, hiking its price target to a Street-high $60. Traffic is still under-monetized withseveral "goldmine" opportunities yet to be unlocked - video ads, games, search, ad network, and Instagram, to name a few. The valuation could reach $97 over time, says CLSA
The Fly On The Wall 9/25/13
September 25, 2013
06:32 EDT FB Facebook price target raised to $54 from $36 at Oppenheimer
Oppenheimer raised its price target for Facebook shares to $54 citing higher usage trends and a $4 per share valuation for Instagram. Opco sees additional upside potential from video ads, the FBX launch into mobile, and increased payments activity. The firm keeps an Outperform rating on the stock.